High-dimensional immune profiles correlate with phenotypes of peanut allergy during food-allergic reactions.

We showed that peripheral immune signatures reflected dynamics of clinical outcome during OFC with peanut. Those immune alterations hold promise as a basis for predictive OFC biomarker discovery to monitor disease outcome and therapy of PA.